Efficacy and Safety of Acne Lotion in the Treatment of Facial Acne Vulgaris
Phase 4
Completed
- Conditions
- Health Condition 1: null- Facial Acne Vulgaris
- Registration Number
- CTRI/2011/05/001758
- Lead Sponsor
- Mayer Organics Pvt Ltd
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 50
Inclusion Criteria
Mild to moderate acne irrespective of sex and social status
-Subjects who have given written informed consent & ascent (where applicable)
Exclusion Criteria
-Participation in another study during the past 30 days
-Cigarette smokers
-Alcoholics & drug abusers
-Pregnant or lactating female
-Females taking contraceptive pills or hormonal preparation
-Use of anti-acne therapy in last 30 days
-Patients having any systemic illness or using any systemic therapy
-Patient with hypersensitivity to sulfur containing drugs
-Poor compliance with study protocol
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method -Reduction in acne number and severity (comedones,Pustules, Nodules) Treatment <br/ ><br>-Change from the baseline in the inflammatory lesion count <br/ ><br>-Change from the baseline in the non-inflammatory lesion count <br/ ><br>Timepoint: 15 Days, 30 Days, 45 Days
- Secondary Outcome Measures
Name Time Method Safety and tolerabilityTimepoint: 15 Days, 30 Days and 45 Days